Merrill Lynch Downgrades Onyx Pharmaceuticals (ONXX) to Underperform
Tweet Send to a Friend
Merrill Lynch downgrades Onyx Pharmaceuticals (Nasdaq: ONXX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
